74 related articles for article (PubMed ID: 2011428)
1. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.
Whitsett JA; Hull WM; Luse S
Pediatrics; 1991 Apr; 87(4):505-10. PubMed ID: 2011428
[TBL] [Abstract][Full Text] [Related]
2. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
Chida S; Phelps DS; Soll RF; Taeusch HW
Pediatrics; 1991 Jul; 88(1):84-9. PubMed ID: 2057277
[TBL] [Abstract][Full Text] [Related]
3. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
4. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement: immunological considerations.
Strayer DS; Merritt TA; Hallman M
Eur Respir J Suppl; 1989 Mar; 3():91s-96s. PubMed ID: 2742687
[TBL] [Abstract][Full Text] [Related]
6. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH
Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary surfactant and the immune system].
Griese M
Monatsschr Kinderheilkd; 1992 Jan; 140(1):57-61. PubMed ID: 1565109
[TBL] [Abstract][Full Text] [Related]
8. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
9. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
Häfner D; Germann PG; Hauschke D
Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
[TBL] [Abstract][Full Text] [Related]
10. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D
Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268
[TBL] [Abstract][Full Text] [Related]
11. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
Friedrich W; Schmalisch G; Stevens PA; Wauer RR
Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein profile of pulmonary surfactant in premature infants.
Ballard PL; Merrill JD; Godinez RI; Godinez MH; Truog WE; Ballard RA
Am J Respir Crit Care Med; 2003 Nov; 168(9):1123-8. PubMed ID: 12904326
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants.
Weber B; Borkhardt A; Stoll-Becker S; Reiss I; Gortner L
Turk J Pediatr; 2000; 42(3):181-5. PubMed ID: 11105614
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a bovine surfactant in very low birth weight premature infants with congenital pneumonia].
Gortner L; Pohlandt F; Bartmann P
Monatsschr Kinderheilkd; 1990 May; 138(5):274-8. PubMed ID: 2377170
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
Ho NK
Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.
Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C
Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907
[TBL] [Abstract][Full Text] [Related]
17. Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome.
Dunn MS; Shennan AT; Possmayer F
Pediatrics; 1990 Oct; 86(4):564-71. PubMed ID: 2216622
[TBL] [Abstract][Full Text] [Related]
18. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
[TBL] [Abstract][Full Text] [Related]
19. Immunologic consequences of exogenous surfactant administration.
Merritt TA; Strayer DS; Hallman M; Spragg RD; Wozniak P
Semin Perinatol; 1988 Jul; 12(3):221-30. PubMed ID: 3041605
[TBL] [Abstract][Full Text] [Related]
20. Immunologic identification of a pulmonary surfactant-associated protein of molecular weight = 6000 daltons.
Whitsett JA; Hull WM; Ohning B; Ross G; Weaver TE
Pediatr Res; 1986 Aug; 20(8):744-9. PubMed ID: 3526265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
